Bard's Gamble on Restructuring
Troubled with severe price pressures, Bard undertakes a major restructuring.
You may also be interested in...
Tyco's acquisition of CR Bard and Medtronic's purchase of MiniMed were announced almost simultaneously, but they hardly are true representations of ongoing consolidation in the medical device industry. Tyco bought Bard for manufacturing and distribution synergies, and Tyco officials talked about leveraging Bard as a growth platform in a slow-growth industry. Medtronic bought insulin pump maker MiniMed to expand into a significantly growing field in which it hasn't yet participated.
If President Donald Trump appoints, and the Senate approves, a new conservative justice for the Supreme Court to replace Ruth Bader Ginsburg, Affordable Care Act coverage could disappear. Two legal experts weigh in on this and other legal issues that could touch the medical device industry.
The Dutch start-up will use the funds to finalize product design for a neurostimulation platform targeting chronic migraines.